Microfluidic Platform

Dr. Hsian-Rong Tseng uses microfluidics, or lab on a chip technology to dramatically reduce the time and resources necessary to study stem cell growth and differentiation at a sub-millimeter scale.

With resources provided by the BSCRC’s research award program combined with a CIRM award, Dr. Tseng has developed and validated a robotic microfluidic platform that allows the manipulation of tiny amounts of fluids at volumes a thousand times smaller than a tear drop. The microfluidic platform can perform chemical screening in search of ideal culture conditions in which stem cells self-renew and differentiate into various cell types. It is also used to screen for small molecules that control self-renewal and differentiation of human pluripotent stem cells.